Cormorant Private Healthcare Fund III LP
Insider CIK 1817320 · OKUR 10% owner · RXDX · RAIN · OLMA 10% owner · PYXS · ELEV 10% owner · ICVX · IMRX 10% owner · DSGN · MLTX 10% owner · GLUE 10% owner · AMAM 10% owner · BLSM 10% owner · BMEA 10% owner · VERV · VTYX 10% owner · TYRA · AMAM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,599,993 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,701,541 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,701,541 | — | $0 | 3,301,534 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,599,993 | — | $0 | 1,599,993 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-10 | 312,500 | $16.00 | $5.00M | 3,614,034 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,701,541 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,599,993 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | P Buy | 2026-08-10 | 2026-08-10 | 312,500 | $16.00 | $5.00M | 3,614,034 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,701,541 | — | — | 3,301,534 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,599,993 | — | — | 1,599,993 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 23,904 | — | $0 | 23,904 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 23,904 | — | $0 | 23,904 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-09-30 | 2025-10-01 | 5,827 | $6.96 | $40.6K | 1,994,173 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-09-29 | 2025-10-01 | 2,800,000 | $6.61 | $18.51M | 2,000,000 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-09-29 | 2025-10-01 | 3,390,943 | $7.58 | $25.70M | 4,800,000 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-09-29 | 2025-10-01 | 70,748 | $9.38 | $663.6K | 8,423,403 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | S Sale | 2025-09-29 | 2025-10-01 | 232,460 | $8.40 | $1.95M | 8,190,943 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-05-15 | 2025-05-19 | 1,813,439 | $1.85 | $3.35M | 0 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | S Sale | 2025-05-12 | 2025-05-14 | 24,300 | $1.99 | $48.4K | 1,813,439 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 100 | $3.05 | $305 | 3,294,773 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 600 | $3.03 | $1.8K | 3,294,173 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 100 | $3.07 | $307 | 3,295,173 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 300 | $3.07 | $921 | 3,294,873 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 398,600 | $2.90 | $1.16M | 2,895,273 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 10 | $3.01 | $30 | 3,294,163 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 10 | $2.98 | $30 | 3,294,153 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-04-01 | 2024-04-03 | 280 | $2.97 | $832 | 3,293,873 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-03-15 | 2024-03-18 | 400,000 | $2.14 | $856.0K | 3,295,273 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-03-14 | 2024-03-18 | 345,266 | $3.24 | $1.12M | 3,859,098 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-03-14 | 2024-03-18 | 98,570 | $4.25 | $418.9K | 3,760,528 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-03-14 | 2024-03-18 | 54,215 | $5.37 | $291.1K | 3,706,313 | SEC↗ |
| IMRX Immuneering Corp | S Sale | 2024-03-14 | 2024-03-18 | 11,040 | $5.97 | $65.9K | 3,695,273 | SEC↗ |
| AMAM Ambrx Biopharma, Inc. | P Buy | 2023-10-23 | 2023-10-25 | 1,307,311 | $6.99 | $9.14M | 11,231,000 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | P Buy | 2023-10-05 | 2023-10-10 | 58,839 | $59.90 | $3.52M | 8,494,151 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | P Buy | 2023-10-04 | 2023-10-04 | 67,814 | $57.32 | $3.89M | 8,435,312 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | P Buy | 2023-10-03 | 2023-10-04 | 150,487 | $57.25 | $8.62M | 8,367,498 | SEC↗ |
| MLTX MoonLake Immunotherapeutic | P Buy | 2023-10-02 | 2023-10-04 | 74,911 | $57.37 | $4.30M | 8,217,011 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-09-18 | 2023-09-19 | 751,233 | $9.24 | $6.94M | 69,465,823 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-09-15 | 2023-09-19 | 1,401,505 | $9.05 | $12.68M | 68,714,590 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-20 | 2023-04-20 | 886,634 | $11.60 | $10.28M | 67,313,085 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-19 | 2023-04-20 | 951,909 | $11.15 | $10.61M | 66,426,451 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-18 | 2023-04-20 | 3,376,646 | $11.27 | $38.05M | 65,474,542 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-17 | 2023-04-17 | 562,121 | $10.67 | $6.00M | 62,097,896 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-14 | 2023-04-17 | 841,967 | $9.96 | $8.39M | 61,535,775 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-04-13 | 2023-04-17 | 1,193,808 | $9.16 | $10.94M | 60,693,808 | SEC↗ |
| BMEA Biomea Fusion, Inc. | P Buy | 2023-03-30 | 2023-04-03 | 400,000 | $30.00 | $12.00M | 3,570,872 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-03-16 | 2023-03-16 | 500,000 | $10.15 | $5.08M | 53,500,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-03-15 | 2023-03-16 | 250,000 | $10.60 | $2.65M | 53,000,000 | SEC↗ |
| AMAM Ambrx Biopharma Inc. | P Buy | 2023-03-14 | 2023-03-16 | 250,000 | $9.95 | $2.49M | 52,750,000 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-27 | 548,288 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-27 | 237,015 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion | 2021-10-25 | 2021-10-27 | 785,303 | — | $0 | 785,303 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | P Buy | 2021-10-25 | 2021-10-27 | 625,000 | $16.00 | $10.00M | 1,410,303 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion deriv | 2021-10-13 | 2021-10-15 | 668,854 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | C Conversion | 2021-10-13 | 2021-10-15 | 668,854 | — | $0 | 668,854 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2021-10-13 | 2021-10-15 | 450,000 | $16.00 | $7.20M | 1,118,854 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-21 | 757,432 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-21 | 757,432 | — | $0 | 757,432 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-21 | 312,500 | $16.00 | $5.00M | 1,069,932 | SEC↗ |
| IMRX Immuneering Corp | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,702,628 | — | $0 | 0 | SEC↗ |
| IMRX Immuneering Corp | P Buy | 2021-08-03 | 2021-08-05 | 550,000 | $15.00 | $8.25M | 2,252,628 | SEC↗ |
| IMRX Immuneering Corp | C Conversion | 2021-08-03 | 2021-08-05 | 1,702,628 | — | $0 | 1,702,628 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-04 | 426,393 | — | $0 | 0 | SEC↗ |
| ICVX Icosavax, Inc. | C Conversion | 2021-08-02 | 2021-08-04 | 426,393 | — | $0 | 426,393 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 1,983,168 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 250,000 | $16.00 | $4.00M | 2,233,168 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,983,168 | — | $0 | 1,983,168 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,124,343 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 477,857 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 600,000 | $19.00 | $11.40M | 3,202,200 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,602,200 | — | $0 | 2,602,200 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 709,224 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 709,224 | — | $0 | 709,224 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-23 | 275,000 | $19.00 | $5.22M | 984,224 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-29 | 2,512,561 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-27 | 2021-04-29 | 450,000 | $17.00 | $7.65M | 2,776,657 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-29 | 2,326,657 | — | $0 | 2,326,657 | SEC↗ |
| BMEA Biomea Fusion, Inc. | C Conversion deriv | 2021-04-20 | 2021-04-22 | 2,270,872 | — | $0 | 0 | SEC↗ |
| BMEA Biomea Fusion, Inc. | P Buy | 2021-04-20 | 2021-04-22 | 900,000 | $17.00 | $15.30M | 3,170,872 | SEC↗ |
| BMEA Biomea Fusion, Inc. | C Conversion | 2021-04-20 | 2021-04-22 | 2,270,872 | — | $0 | 2,270,872 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 1,404,953 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 2,959,891 | — | $0 | 0 | SEC↗ |
| DSGN Design Therapeutics, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 4,364,844 | — | $0 | 4,364,844 | SEC↗ |
| DSGN Design Therapeutics, Inc. | P Buy | 2021-03-30 | 2021-04-01 | 750,000 | $20.00 | $15.00M | 5,114,844 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion deriv | 2021-03-16 | 2021-03-18 | 763,327 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion deriv | 2021-03-16 | 2021-03-18 | 1,084,696 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | C Conversion | 2021-03-16 | 2021-03-18 | 1,848,022 | — | $0 | 1,848,022 | SEC↗ |
| RXDX Prometheus Biosciences, In | P Buy | 2021-03-16 | 2021-03-18 | 375,000 | $19.00 | $7.13M | 2,223,022 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 723,177 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion deriv | 2020-11-23 | 2020-11-23 | 2,122,367 | — | $0 | 0 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | C Conversion | 2020-11-23 | 2020-11-23 | 2,845,544 | — | $0 | 2,845,544 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | P Buy | 2020-11-23 | 2020-11-23 | 425,000 | $19.00 | $8.07M | 3,270,544 | SEC↗ |